西南证券(600369)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

600369 西南证券

已收盘 04-15 15:00:00

{"stockData":{"symbol":"600369","market":"SH","secType":"STK","nameCN":"西南证券","latestPrice":4.25,"timestamp":1776236400000,"preClose":4.28,"halted":0,"volume":22152602,"delay":0,"changeRate":-0.007,"floatShares":6645000000,"shares":6645000000,"eps":0.2145,"marketStatus":"已收盘","change":-0.03,"latestTime":"04-15 15:00:00","open":4.28,"high":4.29,"low":4.24,"amount":94482300,"amplitude":0.0117,"askPrice":4.25,"askSize":141,"bidPrice":4.24,"bidSize":6108,"shortable":0,"etf":0,"ttmEps":0.2145,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776303000000},"marketStatusCode":5,"adr":0,"adjPreClose":4.28,"symbolType":"stock","openAndCloseTimeList":[[1776216600000,1776223800000],[1776229200000,1776236400000]],"highLimit":4.71,"lowLimit":3.85,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":6645109124,"isCdr":false,"pbRate":1.08,"roa":"--","peRate":19.81352,"roe":"4.08%","epsLYR":0.16,"committee":-0.274427,"marketValue":28242000000,"turnoverRate":0.0033,"status":1,"floatMarketCap":28242000000},"requestUrl":"/m/hq/s/600369","defaultTab":"news","newsList":[{"id":"2627273404","title":"众兴菌业涨6.22%，西南证券三周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2627273404","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627273404?lang=zh_cn&edition=full","pubTime":"2026-04-15 16:11","pubTimestamp":1776240690,"startTime":"0","endTime":"0","summary":"今日众兴菌业涨6.22%，收盘报17.93元。2026年3月24日，西南证券研究员徐卿,赵磐发布了对众兴菌业的研报《2025年报点评：主营回暖净利高增，冬虫夏草打开新成长空间》，该研报对众兴菌业给出“买入”评级。研报中预计2026-2028年EPS分别为0.98元、1.07元、1.19元，对应动态PE分别为18/16/15倍。维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为西南证券的徐卿、赵磐。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500028577.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600369","002772"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627419055","title":"西南证券：给予美格智能增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2627419055","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627419055?lang=zh_cn&edition=full","pubTime":"2026-04-14 17:05","pubTimestamp":1776157550,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司叶泽佑近期对美格智能进行研究并发布了研究报告《2025年年报点评：海外与无线宽带驱动规模扩张，AI模组打开成长空间》，给予美格智能增持评级。公司26年规划目标积极，改革动作持续落地，看好全年加速成长，首次覆盖给予“持有”评级。最新盈利预测明细如下：该股最近90天内共有5家机构给出评级，买入评级3家，增持评级2家；过去90天内机构目标均价为43.64。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041400027203.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600369","002881","03268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627490394","title":"西南证券：3月工程机械内销恢复 出口继续高增","url":"https://stock-news.laohu8.com/highlight/detail?id=2627490394","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627490394?lang=zh_cn&edition=full","pubTime":"2026-04-14 14:26","pubTimestamp":1776147971,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，西南证券发布研报称，2026年3月，工程机械景气度延续抬升，“更新周期+外需拉动”仍是主线。3月挖机销量同比增长26%，带动一季度销量累计同比增长19%，出口累计同比增长36%，内销累计同比增长8%。西南证券主要观点如下：挖掘机：2026年3月，挖掘机销量为37402台，同比增长26.4%。其中，国内销量为9521台，同比增长16.6%；出口销量为7505台，同比增长30.5%。电动装载机3月销量为5163台；一季度销量合计10295台。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428188.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","BK0183","BK0276","BK0012","BK0028","159542","600369"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627949044","title":"西南证券：给予云天化买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2627949044","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627949044?lang=zh_cn&edition=full","pubTime":"2026-04-14 13:25","pubTimestamp":1776144315,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司甄理,钱伟伦近期对云天化进行研究并发布了研究报告《2025年年报点评：化肥销量平稳，分红维持较高水平》，给予云天化买入评级。预计2026-2028年EPS分别为2.83元、3.15元、3.41元，对应PE分别为12倍、11倍、10倍，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有19家机构给出评级，买入评级16家，增持评级3家；过去90天内机构目标均价为44.14。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041400018287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600369","600096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626171877","title":"西南证券：给予晨光生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2626171877","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626171877?lang=zh_cn&edition=full","pubTime":"2026-04-12 14:45","pubTimestamp":1775976315,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司朱会振,舒尚立近期对晨光生物进行研究并发布了研究报告《2025年报点评：棉籽大幅扭亏，上行拐点将至》，给予晨光生物买入评级。　　盈利预测与投资建议：预计2026-2028年归母净利润分别为4.5、5.5、6.3亿元，EPS分别为0.93元、1.14元、1.31元，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有7家机构给出评级，买入评级5家，增持评级2家；过去90天内机构目标均价为15.66。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041200002739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300138","600369"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626162468","title":"西南证券：风险出清+双轮驱动 CXO有望开启景气上行周期","url":"https://stock-news.laohu8.com/highlight/detail?id=2626162468","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626162468?lang=zh_cn&edition=full","pubTime":"2026-04-10 15:20","pubTimestamp":1775805627,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，西南证券发布研报称，2026年一季度，CXO板块风险出清、业绩分化、双轮驱动，板块有望进入新一轮景气上行周期。2026年一季度，CXO板块风险出清、业绩分化、双轮驱动：美国政策不确定性缓和，地缘压制消退、估值修复动力足;龙头(药明系)与CDMO业绩高增、临床CRO企稳，结构性行情显著;海外研发回暖+国内创新药市场修复共振，订单饱满锁定2026-2027年增长，板块有望进入新一轮景气上行周期。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1427015.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CXO","BK0012","BK0028","600369","BK0183","BK0188","BK0276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626151918","title":"西南证券：给予新宙邦买入评级，目标价73.08元","url":"https://stock-news.laohu8.com/highlight/detail?id=2626151918","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626151918?lang=zh_cn&edition=full","pubTime":"2026-04-10 08:32","pubTimestamp":1775781143,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司钱伟伦近期对新宙邦进行研究并发布了研究报告《2025年年报点评：有机氟稳健增长，锂电迎盈利修复》，给予新宙邦买入评级，目标价73.08元。最新盈利预测明细如下：该股最近90天内共有11家机构给出评级，买入评级9家，增持评级2家；过去90天内机构目标均价为76.61。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041000007600.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300037","600369"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625894373","title":"西南证券：给予牧原股份买入评级，目标价55.92元","url":"https://stock-news.laohu8.com/highlight/detail?id=2625894373","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625894373?lang=zh_cn&edition=full","pubTime":"2026-04-08 19:15","pubTimestamp":1775646932,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司徐卿,赵磐近期对牧原股份进行研究并发布了研究报告《2025年年报点评：成本优势持续强化，屠宰业务首次盈利，海外布局加速》，给予牧原股份买入评级，目标价55.92元。最新盈利预测明细如下：该股最近90天内共有22家机构给出评级，买入评级19家，增持评级3家；过去90天内机构目标均价为59.73。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040800032482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02714","002714","600369"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625943787","title":"西南证券：首次覆盖麦加芯彩给予买入评级，目标价54.72元","url":"https://stock-news.laohu8.com/highlight/detail?id=2625943787","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625943787?lang=zh_cn&edition=full","pubTime":"2026-04-08 19:15","pubTimestamp":1775646922,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司胡光怿,钱伟伦,杨蕊近期对麦加芯彩进行研究并发布了研究报告《2025年年报点评：业务结构持续优化，盈利能力提升维持高派息》，首次覆盖麦加芯彩给予买入评级，目标价54.72元。2025年全年实现营业收入17.12亿元，实现归属于上市公司股东的净利润2.10亿元。2025年公司收入受影响下滑20%，为17.12亿元。最新盈利预测明细如下：该股最近90天内共有5家机构给出评级，买入评级3家，增持评级2家；过去90天内机构目标均价为59.5。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040800032472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600369","603062"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625691127","title":"众兴菌业涨5.09%，西南证券二周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2625691127","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625691127?lang=zh_cn&edition=full","pubTime":"2026-04-08 16:55","pubTimestamp":1775638503,"startTime":"0","endTime":"0","summary":"今日众兴菌业涨5.09%，收盘报17.34元。2026年3月24日，西南证券研究员徐卿,赵磐发布了对众兴菌业的研报《2025年报点评：主营回暖净利高增，冬虫夏草打开新成长空间》，该研报对众兴菌业给出“买入”评级。研报中预计2026-2028年EPS分别为0.98元、1.07元、1.19元，对应动态PE分别为18/16/15倍。维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为西南证券的徐卿、赵磐。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040800025829.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002772","600369"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625138919","title":"中创智领涨5.46%，西南证券一日前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2625138919","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625138919?lang=zh_cn&edition=full","pubTime":"2026-04-08 16:31","pubTimestamp":1775637084,"startTime":"0","endTime":"0","summary":"今日中创智领涨5.46%，收盘报20.65元。2026年4月7日，西南证券研究员邰桂龙,杨云杰发布了对中创智领的研报《2025年年报点评：三大板块齐头并进，汽零业务利润高增》，该研报对中创智领给出“买入”评级。公司煤机板块稳健发展，汽零板块盈利能力持续修复，工业智能板块打造第三增长极，维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为广发证券的李爽。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040800025109.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["00564","600369","601717"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625919195","title":"博汇纸业涨5.24%，西南证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2625919195","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625919195?lang=zh_cn&edition=full","pubTime":"2026-04-08 16:29","pubTimestamp":1775636952,"startTime":"0","endTime":"0","summary":"今日博汇纸业涨5.24%，收盘报6.63元。2026年2月24日，西南证券研究员蔡欣,沈琪发布了对博汇纸业的研报《白卡龙头迎周期拐点，整合预期打开成长空间》，该研报对博汇纸业给出“买入”评级。给予“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为14.25%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为民生证券的胡皓寒。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040800025041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600966","600369"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625332989","title":"瑞普生物涨7.70%，西南证券四日前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2625332989","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625332989?lang=zh_cn&edition=full","pubTime":"2026-04-07 16:22","pubTimestamp":1775550168,"startTime":"0","endTime":"0","summary":"今日瑞普生物涨7.70%，收盘报18.88元。2026年4月3日，西南证券研究员徐卿,赵磐发布了对瑞普生物的研报《2025年年报点评：业绩高增，宠物与生物制造双轮驱动长期成长》，该研报对瑞普生物给出“买入”评级。研报中预计2026~2028年公司EPS为1.07、1.26、1.57元，对应动态PE16、14、11倍，维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为中信证券的施杨。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700021956.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600369","300119"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625811529","title":"西南证券：给予中创智领买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2625811529","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625811529?lang=zh_cn&edition=full","pubTime":"2026-04-07 12:30","pubTimestamp":1775536243,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司邰桂龙,杨云杰近期对中创智领进行研究并发布了研究报告《2025年年报点评：三大板块齐头并进，汽零业务利润高增》，给予中创智领买入评级。公司煤机板块稳健发展，汽零板块盈利能力持续修复，工业智能板块打造第三增长极，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有5家机构给出评级，买入评级4家，增持评级1家；过去90天内机构目标均价为25.0。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700014115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["00564","601717","600369"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624561659","title":"西南证券：给予瑞普生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2624561659","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624561659?lang=zh_cn&edition=full","pubTime":"2026-04-03 17:30","pubTimestamp":1775208650,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司徐卿,赵磐近期对瑞普生物进行研究并发布了研究报告《2025年年报点评：业绩高增，宠物与生物制造双轮驱动长期成长》，给予瑞普生物买入评级。其中，禽用生物制品市场占有率约为17.94%，保持行业领先地位。报告期内，公司研发投入超3亿元，占营业收入比重8.83%。最新盈利预测明细如下：该股最近90天内共有8家机构给出评级，买入评级8家；过去90天内机构目标均价为23.23。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300034429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300119","600369"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624878632","title":"西南证券：给予有友食品买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2624878632","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624878632?lang=zh_cn&edition=full","pubTime":"2026-04-03 12:01","pubTimestamp":1775188874,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司朱会振,舒尚立近期对有友食品进行研究并发布了研究报告《2025年报点评：2025年顺利收官，期待新兴渠道表现》，给予有友食品买入评级。　　盈利预测与投资建议：预计2026-2028年EPS分别为0.61元、0.74元、0.87元，对应动态PE分别为18倍、15倍、13倍，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有6家机构给出评级，买入评级5家，增持评级1家；过去90天内机构目标均价为14.56。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300020696.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600369","603697"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624624509","title":"西南证券：给予青岛啤酒买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2624624509","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624624509?lang=zh_cn&edition=full","pubTime":"2026-04-02 20:25","pubTimestamp":1775132720,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司朱会振,舒尚立近期对青岛啤酒进行研究并发布了研究报告《2025年报点评：2025年稳健收官，静待需求回暖》，给予青岛啤酒买入评级。全年毛利率提升主要系啤酒原材料价格持续下行所致。最新盈利预测明细如下：该股最近90天内共有23家机构给出评级，买入评级18家，增持评级5家；过去90天内机构目标均价为78.81。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200038541.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600600","600369"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624778705","title":"西南证券：给予华能国际买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2624778705","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624778705?lang=zh_cn&edition=full","pubTime":"2026-04-02 17:29","pubTimestamp":1775122149,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司韩晨,巢语欢近期对华能国际进行研究并发布了研究报告《2025年年报点评：火电盈利持续提升，重视高股息配置价值》，给予华能国际买入评级。　　新加坡/巴基斯坦利润总额同比分别-5.7/-1.1亿元。预计公司26-28年归母净利润分别为142.8亿元/147.2亿元/152.6亿元，对应EPS分别为0.91/0.94/0.97元，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有14家机构给出评级，买入评级13家，增持评级1家；过去90天内机构目标均价为9.96。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200030067.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600369","600011"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624579036","title":"中牧股份涨7.12%，西南证券三周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2624579036","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624579036?lang=zh_cn&edition=full","pubTime":"2026-04-02 16:05","pubTimestamp":1775117144,"startTime":"0","endTime":"0","summary":"今日中牧股份涨7.12%，收盘报8.12元。2026年3月6日，西南证券研究员徐卿,赵磐发布了对中牧股份的研报《拟收购中核铀业控股子公司，增强公司化药原料端自主可控与产业链协同》，该研报对中牧股份给出“买入”评级。研报中预计2025~2027年公司EPS为0.19、0.31、0.38元，对应动态PE39、24、20倍，维持“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为34.41%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200025985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600369","600195"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624781875","title":"西南证券：给予国邦医药买入评级，目标价38.2元","url":"https://stock-news.laohu8.com/highlight/detail?id=2624781875","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624781875?lang=zh_cn&edition=full","pubTime":"2026-04-02 14:10","pubTimestamp":1775110231,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司徐卿,赵磐近期对国邦医药进行研究并发布了研究报告《2025年年报点评：动保业务驱动增长，平台优势巩固国际竞争力》，给予国邦医药买入评级，目标价38.2元。医药业务：实现收入34.75亿元，同比下降9.08%，毛利率为28.34%，基本保持稳定。预计2026-2028年EPS分别为1.91元、2.28元、2.56元，对应动态PE分别为13/11/10倍；予以公司2026年20倍PE，目标价38.2元，维持“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200018835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600369","605507"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1776282079888,"stockEarnings":[{"period":"1week","weight":0.0024},{"period":"1month","weight":-0.0275},{"period":"3month","weight":-0.0535},{"period":"6month","weight":-0.0841},{"period":"1year","weight":0.0609},{"period":"ytd","weight":-0.0513}],"compareEarnings":[{"period":"1week","weight":0.0081},{"period":"1month","weight":-0.0141},{"period":"3month","weight":-0.0208},{"period":"6month","weight":0.0488},{"period":"1year","weight":0.2324},{"period":"ytd","weight":0.0147}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"西南证券股份有限公司","boardCode":"AI0067","boardName":"资本市场服务","stockholders":"112816人(较上一季度减少1.15%)","perCapita":"58902股","listingDate":"2001-01-09","address":"重庆市两江新区金沙门路32号","registeredCapital":"664510万元","survey":"　　西南证券股份有限公司的主营业务是证券及期货经纪业务、投资银行业务、自营业务、资产管理业务等。公司的主要产品是证券及期货经纪业务、投资银行业务、自营业务、资产管理业务。","listedPrice":6.18},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.41.0","shortVersion":"4.41.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"西南证券(600369)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供西南证券(600369)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"西南证券,600369,西南证券股票,西南证券股票老虎,西南证券股票老虎国际,西南证券行情,西南证券股票行情,西南证券股价,西南证券股市,西南证券股票价格,西南证券股票交易,西南证券股票购买,西南证券股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"西南证券(600369)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供西南证券(600369)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}